MedPath

M-RIZATRIPTAN ODT

M-RIZATRIPTAN ODT

Approved
DIN Number

02548828

Drug Class

Human

Market Date

Jun 10, 2025

Company
HC

mantra pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02548828
AIG Number0137841002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02CC04 RIZATRIPTAN
Product Specifications
Dosage FormTablet (Orally Disintegrating)
Route of AdministrationOral
AHFS Classification28:32.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIZATRIPTAN (RIZATRIPTAN BENZOATE)Active
Strength: 10 MG
Monograph: RIZATRIPTAN (RIZATRIPTAN BENZOATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.